Publikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (46)

2024

  1. Deactivation of internal recirculation in a full-scale Biological Nutrient Removal (BNR) Wastewater Treatment Plant (WWTP) reveals outstanding microeukaryotic bioindicators

    Journal of Water Process Engineering, Vol. 57

2023

  1. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

  2. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

    British Journal of Haematology

  3. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Genetic Variability of Polypedilum (Diptera: Chironomidae) from Southwest Ecuador

    Insects, Vol. 13, Núm. 4

  2. Niche differentiation drives microbial community assembly and succession in full-scale activated sludge bioreactors

    npj Biofilms and Microbiomes, Vol. 8, Núm. 1

  3. The insecticides permethrin and chlorpyrifos show limited genotoxicity and no leukemogenic potential in human and murine hematopoietic stem progenitor cells

    Haematologica

2021

  1. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

    Nature Communications, Vol. 12, Núm. 1

  2. Alterations in slc4a2, slc26a7 and slc26a9 drive acid–base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario

    Cells, Vol. 10, Núm. 12

  3. High mutational heterogeneity, and new mutations in the human coagulation factor v gene. Future perspectives for factor v deficiency using recombinant and advanced therapies

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  4. Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects

    Scientific Reports, Vol. 11, Núm. 1

  5. Targeting OGG1 arrests cancer cell proliferation by inducing replication stress

    Nucleic Acids Research, Vol. 48, Núm. 21, pp. 12234-12251

2020

  1. Clinical and Molecular Description of 16 Families With Heterozygous IHH Variants

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 8

  2. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

  3. In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    Nature Communications, Vol. 11, Núm. 1

  4. RIAM-VASP Module Relays Integrin Complement Receptors in Outside-In Signaling Driving Particle Engulfment

    Cells, Vol. 9, Núm. 5

  5. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells

    Molecular Therapy - Nucleic Acids, Vol. 20, pp. 196-204

  6. Two multi-fragment recombination events resulted in the β-lactam-resistant serotype 11A-ST6521 related to Spain9V-ST156 pneumococcal clone spreading in south-western Europe, 2008 to 2016

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 25, Núm. 16

2019

  1. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

  2. Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL

    Cancer Immunology Research, Vol. 7, Núm. 4, pp. 644-657